Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
9.15
-0.23 (-2.45%)
Apr 9, 2026, 11:23 AM EDT - Market open
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.38 billion as of April 9, 2026. Its market cap has decreased by -56.56% in one year.
Market Cap
1.38B
Enterprise Value
1.33B
1-Year Change
-56.56%
Ranking
Category
Stock Price
$9.15
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.38B, an increase of 426.17%. That is a compound annual growth rate of 59.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 1.41B | -5.81% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 1.45B |
| Precigen | 1.44B |
| Nanobiotix | 1.44B |
| Bicara Therapeutics | 1.42B |
| Maze Therapeutics | 1.40B |
| Immatics | 1.40B |
| AtaiBeckley | 1.38B |
| Olema Pharmaceuticals | 1.37B |